Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bone disorders: targeting NOX4 knocks down osteoporosis.

× No keyword cloud information.

1 in total

1. NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.

Authors: Claudia Goettsch; Andrea Babelova; Olivia Trummer; Reinhold G Erben; Martina Rauner; Stefan Rammelt; Norbert Weissmann; Valeska Weinberger; Sebastian Benkhoff; Marian Kampschulte; Barbara Obermayer-Pietsch; Lorenz C Hofbauer; Ralf P Brandes; Katrin Schröder
Journal: J Clin Invest Date: 2013-11 Impact factor: 14.808

1 in total

5 in total

1. A surprising mediator of oxidative DNA damage.

Authors: Efrat Dvash; Menachem Rubinstein
Journal: Cell Cycle Date: 2016-02-18 Impact factor: 4.534

2. Reactive oxygen species are required for zoledronic acid-induced apoptosis in osteoclast precursors and mature osteoclast-like cells.

Authors: Ta-Wei Tai; Ching-Yu Chen; Fong-Chin Su; Yuan-Kun Tu; Tsung-Ting Tsai; Chiou-Feng Lin; I-Ming Jou
Journal: Sci Rep Date: 2017-03-10 Impact factor: 4.379

3. Overexpression of mechanical sensitive miR-337-3p alleviates ectopic ossification in rat tendinopathy model via targeting IRS1 and Nox4 of tendon-derived stem cells.

Authors: Yiyun Geng; Xiaoying Zhao; Jiajia Xu; Xudong Zhang; Guoli Hu; Sai-Chuen Fu; Kerong Dai; Xiaodong Chen; Yung Shu-Huang Patrick; Xiaoling Zhang
Journal: J Mol Cell Biol Date: 2020-05-18 Impact factor: 6.216

4. Protective effect of resveratrol on estrogen deficiency-induced osteoporosis though attenuating NADPH oxidase 4/nuclear factor kappa B pathway by increasing miR-92b-3p expression.

Authors: Ye Zhang; Ming-Wei Liu; Yun He; Ning Deng; Yan Chen; Jiecong Huang; Wei Xie
Journal: Int J Immunopathol Pharmacol Date: 2020 Jan-Dec Impact factor: 3.219

Review 5. Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review.

Authors: Lianwei Wang; Dengyang Fang; Jinming Xu; Runlan Luo
Journal: BMC Cancer Date: 2020-11-03 Impact factor: 4.430

5 in total